Single-case experimental designs for bumetanide across neurodevelopmental disorders: BUDDI protocol
Abstract Background Bumetanide is a selective NKCC1 chloride importer antagonist which is being repurposed as a mechanism-based treatment for neurodevelopmental disorders (NDDs). Due to their specific actions, these kinds of interventions will only be effective in particular subsets of patients. To...
में बचाया:
| मुख्य लेखकों: | , , , , , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
BMC
2022-07-01
|
| श्रृंखला: | BMC Psychiatry |
| विषय: | |
| ऑनलाइन पहुंच: | https://doi.org/10.1186/s12888-022-04033-8 |
| टैग: |
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|